Search research articles
Contact Us
Filters
Showing results (131-140 of 147) with videos related to
Page
of 15
Sort By:
Current Oncology (Toronto, Ont.)
|
June 25, 2026
A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma
Lee Mozessohn, Pierre J A Villeneuve, Nibene H Somé, et al.
Current Oncology (Toronto, Ont.)
|
April 26, 2024
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration
Pam Takhar, Marc Geirnaert, Scott Gavura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 2, 2019
Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline
Joseph Mikhael, Nofisat Ismaila, Matthew C Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2026
Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1
Rahul Banerjee, Matthew C Cheung, Benjamin Derman, et al.
JAMA Network Open
|
August 2, 2022
Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada
Steven Habbous, Xiaochen Tai, Jaclyn M Beca, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 2, 2021
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia
Matthew C Cheung, Nicole Mittmann, Carolyn Owen, et al.
Cancer Cytopathology
|
December 27, 2022
Small volume biopsy diagnostic yield at initial diagnosis versus recurrence/transformation of follicular lymphoma: A retrospective Cyto-Heme Interinstitutional Collaborative study
Megan J Fitzpatrick, Vandana Sundaram, Amy Ly, et al.
Haematologica
|
December 15, 2015
Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma
Meletios A Dimopoulos, Matthew C Cheung, Murielle Roussel, et al.
Leukemia & Lymphoma
|
June 28, 2021
Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation
Eric Mou, Lorenzo Falchi, Vandana Sundaram, et al.
Journal of Gynecologic Oncology
|
October 25, 2024
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial
Janice S Kwon, Helen McTaggart-Cowan, Sarah E Ferguson, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 147) with videos related to
Sort By:
Page
of 15
Current Oncology (Toronto, Ont.)
|
June 25, 2026
A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma
Lee Mozessohn, Pierre J A Villeneuve, Nibene H Somé, et al.
Current Oncology (Toronto, Ont.)
|
April 26, 2024
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration
Pam Takhar, Marc Geirnaert, Scott Gavura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 2, 2019
Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline
Joseph Mikhael, Nofisat Ismaila, Matthew C Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2026
Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1
Rahul Banerjee, Matthew C Cheung, Benjamin Derman, et al.
JAMA Network Open
|
August 2, 2022
Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada
Steven Habbous, Xiaochen Tai, Jaclyn M Beca, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 2, 2021
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia
Matthew C Cheung, Nicole Mittmann, Carolyn Owen, et al.
Cancer Cytopathology
|
December 27, 2022
Small volume biopsy diagnostic yield at initial diagnosis versus recurrence/transformation of follicular lymphoma: A retrospective Cyto-Heme Interinstitutional Collaborative study
Megan J Fitzpatrick, Vandana Sundaram, Amy Ly, et al.
Haematologica
|
December 15, 2015
Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma
Meletios A Dimopoulos, Matthew C Cheung, Murielle Roussel, et al.
Leukemia & Lymphoma
|
June 28, 2021
Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation
Eric Mou, Lorenzo Falchi, Vandana Sundaram, et al.
Journal of Gynecologic Oncology
|
October 25, 2024
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial
Janice S Kwon, Helen McTaggart-Cowan, Sarah E Ferguson, et al.
Page
of 15